In the article “Younger women with gynecologic cancers at high risk for osteoporosis 1 year after treatment”, Sobecki shared findings from her study that assessed long-term changes in bone mineral density among women who underwent oophorectomy for uterine or ovarian cancer.
“Current guidelines support routine bone mineral density evaluation every 2 years for women with cancer who undergo treatments that affect ovarian function. However, these data largely are based on research of patients with breast cancer, Sobecki said.
“Nearly all women with gynecologic cancer undergo oophorectomy in addition to other cancer-directed therapies, which are known risk factors for bone loss. Yet, few data exist regarding bone loss in this population,” Sobecki told Healio. “Given [women with gynecologic cancer] undergo CT imaging often throughout their treatment course, we believed opportunistic CT bone mineral density evaluation would be an easy and effective way to investigate bone loss in our patient population.””
Read the whole article here!